Strength

10; 25; 40 mg/1; mg/1; mg/1

NDC

00713087830

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

9/17/2025

Approval Type

New Drug (NDA)

FDA Application

NDA200175

On Market Since

9/1/2022

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.1%

3Y

N/A

5Y

N/A

All

+10.2%